Edward N. van den Brink

Author

Also Known As

E. N. Van Den Brink, E. N. van den Brink, Edward N van den Brink, Edward N. Van Den Brink, Edward N. van den Brink, Simone Timmermans

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Emma Kinderziekenhuis Genmab (Netherlands)Leiden University Medical Center Johnson & Johnson (Netherlands)

About

Edward N. van den Brink is an author at University of Amsterdam specializing in medicine, gene expression, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	181
2	Cell Biology	1	1	13
3	Cellular Physiology	1	1	13
4	Immunology	1	1	168
5	Cell Signaling	1	1	13

Edward N. van den Brink

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants Jan ter Meulen, Edward N. van den Brink, Leo L. M. Poon, PLoS Medicine	2006	737
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets Jan ter Meulen, Alexander B. H. Bakker, Edward N. van den Brink, The Lancet	2004	274
Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus Edward N. van den Brink, Jan ter Meulen, Freek Cox, Journal of Virology Nucleocapsid ProteinsVirus StructureLinear EpitopeRespiratory DiseasesViral Pathogenesis	2005	168
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing Patrick Engelberts, Ida H. Hiemstra, Bart de Jong, EBioMedicine	2020	159
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors Alexander Muik, Elena Garralda, Friederike Gieseke, Cancer Discovery	2022	104
The Missense Mutation Arg593 → Cys Is Related to Antibody Formation in a Patient With Mild Hemophilia A Karin Fijnvandraat, Ellen A.M. Turenhout, Edward N. van den Brink, Blood	1997	79
DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies Simone C. Oostindie, Hilma J. van der Horst, Laurens P. Kil, Blood Cancer Journal	2020	68
Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes Edward N. van den Brink, Ellen A.M. Turenhout, Julian Davies, Blood	2000	52
Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII Edward N. van den Brink, Ellen A.M. Turenhout, Niels Bovenschen, Blood	2001	41
Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain Edward N. van den Brink, Ellen A.M. Turenhout, Christine M.C. Bank, Blood	2000	38

Page 1